Due to the increased risk of ASCVD in patients with HIV, aggressive treatment with lifestyle modifications and lipid-lowering therapy are generally recommended.
Researchers from the University of Montreal Hospital Research Centre are leading a team developing a saliva test that can predict the risk of complications from diabetes.
'Our survival outcomes from cardiac arrest resuscitation have not changed very much for 60 years because we haven't developed new treatments and innovative methods. Unlike the rest of medicine, we're living in the past.'